ACTIVITY OF 4-DEMETHOXYDAUNORUBICIN BY THE ORAL ROUTE IN ADVANCED BREAST-CANCER

被引：40

作者：

MARTONI, A

PACCIARINI, MA

PANNUTI, F

机构：

[1] S ORSOLA MALPIGHI HOSP,DIV ONCOL,VIA ALBERTONI 15,I-40138 BOLOGNA,ITALY

[2] FARMITALIA CARLO ERBA SPA,CLIN PHARMACOL,MILANO,ITALY

来源：

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1985年 / 21卷 / 07期

关键词：

D O I：

10.1016/0277-5379(85)90218-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：803 / 806

页数：4

共 11 条

[1] ARCAMONE F, 1976, CANCER TREAT REP, V60, P829
[2] BERMAN E, 1983, CANCER RES, V43, P6096
[3] Bonfante V, 1983, Invest New Drugs, V1, P161
[4] BROGGINI M, 1984, CANCER TREAT REP, V68, P739
[5] CASAZZA AM, 1979, P AM ASSOC CANC RES, V20, P16
[6] CASAZZA AM, 1979, CANCER TREAT REP, V63, P835
[7] DIMARCO A, 1977, CANCER TREAT REP, V61, P893
[8] PHASE-I TRIAL OF 4-DEMETHOXYDAUNORUBICIN WITH SINGLE IV DOSES
KAPLAN, S
MARTINI, A
VARINI, M
TOGNI, P
CAVALLI, F
[J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1982, 18 (12): : 1303 - 1306
[9] MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO
[10] 2-6